Skip to content
Screener

Adaptive Biotechnologies ADPT Q1 2025 earnings

Reported May 1, 2025 · After market close

Revenue$52.4MBeat by $10.3M
EPS-$0.20Beat by $0.08
Revenue estimate$42.1M
EPS estimate-$0.28

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$71.6M
EPS estimate-$0.10

Financials

Q1 2025

Income statement

See full
Revenue$52.4M+25.2%
Gross profit$35.5M+48.9%
Operating income-$29.6M+39.3%
Net income-$29.9M+37.2%
EPS (diluted)-$0.20+39.4%

Balance sheet

See full
Cash & equivalents$50.6M-28.9%
Total debt$220.5M-3.3%
Total equity$190.4M-30.7%
Total assets$510.9M-17.6%

Cash flow

See full
Operating cash flow-$28.5M+25.7%
CapEx$1.3M-16.7%
Free cash flow-$29.7M+25.4%

Valuation & ratios

Valuation

as of 03/31/25
See full
Market cap$1.1B+137%
Enterprise value$1.27B+105%
P/S5.8×+3.2×

Profitability

See full
Gross margin62.5%+5.5pp
Operating margin-75.7%-21.5pp
Net margin-74.8%-21.1pp
FCF margin-46.8%-14.2pp

Returns & leverage

See full
Return on equity-61%-0.6pp
Debt / equity1.2×+0.3×
Current ratio2.9×-1.6×

Segments

By product

See full
Service$39.2M+39.4%
Regulatory Milestone Revenue$4.5M0.0%
Collaboration Revenue$3.6M-23.2%

By segment

See full
Mrd Business$43.7M+34.0%
Immune Medicine Business$8.7M-5.7%

FAQ

When did Adaptive Biotechnologies report Q1 2025 earnings?
Adaptive Biotechnologies (ADPT) reported Q1 2025 earnings on May 1, 2025 after market close.
What were Adaptive Biotechnologies's Q1 2025 revenue and EPS?
Adaptive Biotechnologies reported revenue of $52.4M and eps of $-0.20 for Q1 2025.
Did Adaptive Biotechnologies beat estimates in Q1 2025?
Revenue beat the consensus estimate of $42.1M by $10.3M. EPS beat the consensus estimate of $-0.28 by $0.08.
How did Adaptive Biotechnologies's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 25.2% from $41.9M a year earlier and eps grew 39.4% from $-0.33.
Where can I find Adaptive Biotechnologies's Q1 2025 SEC filings?
You can read the 8-K earnings release (0000950170-25-061851) and the 10-Q periodic report (0000950170-25-061897) directly on SEC EDGAR. The filing index links above go to sec.gov.